Reduced expression of steroid sulfatase in primary colorectal cancer

Rawluszko, AA; Antoniucci, M; Horbacka, K; Lianeri, M; Krokowicz, P; Jagodzinski, PP

HERO ID

2279788

Reference Type

Journal Article

Year

2013

Language

English

PMID

23916543

HERO ID 2279788
In Press No
Year 2013
Title Reduced expression of steroid sulfatase in primary colorectal cancer
Authors Rawluszko, AA; Antoniucci, M; Horbacka, K; Lianeri, M; Krokowicz, P; Jagodzinski, PP
Journal Biomedicine & Pharmacotherapy
Volume 67
Issue 7
Page Numbers 577-582
Abstract Colorectal cancer (CRC) is considered an estrogen-dependent malignancy, and intratissue estrogen concentration can be controlled by steroid sulfatase (STS). Little is known about changes in the expression of STS during the development of CRC. Therefore, we analysed the STS mRNA levels in primary colonic adenocarcinoma tissues and adjacent histopathologically unchanged colonic mucosa from patients who underwent radical colon resection (n=90). We found a statistically significant decrease in STS transcript levels in CRC (P=0.0453). Moreover, we found that sodium butyrate (NaBu) significantly upregulated STS transcript levels in DLD-1 and HCT116 CRC cells. Our results suggest that STS expression can be decreased in the process of large intestinal carcinogenesis. Moreover, we observed that NaBu might increase STS expression in CRC cells.
Doi 10.1016/j.biopha.2013.04.007
Pmid 23916543
Wosid WOS:000325967400004
Is Certified Translation No
Dupe Override No
Comments Journal: Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie ISSN: 1950-6007
Is Public Yes
Language Text English
Keyword Steroid sulfatase; Butyrate; Colorectal cancer